Uncategorized

By Dr. Harriet Kamendi, PhD — Regulatory Toxicologist & CEO, Kandih BioScience  Signal-Dense Opening According to a report from the Austin American-Statesman, Neuralink — the Elon […]

DIC is caused by another medical condition that makes the body’s normal blood clotting process become overactive. The condition progresses through two stages. In the early stages, overactive clotting leads to blood clots throughout the blood vessels. The clots can reduce or block blood flow, damaging organs. As DIC progresses, the overactive clotting uses up platelets and clotting factors, which are protein that help with normal blood clotting. Without these platelets and clotting factors, DIC can cause bleeding just beneath the skin, in the nose or mouth, or deep inside the body.

When Discovery Meets Responsibility Scientists in Brazil have discovered a previously unknown coronavirus in bats — one that carries genetic similarities to MERS-CoV, the virus responsible for deadly outbreaks in the Middle East. (University of Nebraska Medical Center, 2025 ) For professionals in biotech, toxicology, and product development, the message is urgent and clear:

Mechanism Meets Safety Lynkuet (elinzanetant) is one of the first non-hormonal medicines approved to treat moderate to severe hot flashes and night sweats caused by menopause (EMA, 2025). It’s a major step forward — and a powerful reminder for developers of one core truth: